Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNT1 | O60563 | 14/20 | 0.67 |
| ▸ | CDK1 | P06493 | 14/20 | 0.67 |
| ▸ | CCNB1 | P14635 | 14/20 | 0.67 |
| ▸ | CCNE1 | P24864 | 14/20 | 0.67 |
| ▸ | CDK2 | P24941 | 14/20 | 0.67 |
| ▸ | CDK9 | P50750 | 14/20 | 0.67 |
| ▸ | CDK7 | P50613 | 13/20 | 0.67 |
| ▸ | CCNH | P51946 | 13/20 | 0.67 |
| ▸ | CDK4 | P11802 | 12/20 | 0.67 |
| ▸ | CCND1 | P24385 | 12/20 | 0.67 |
| ▸ | MAPT | P10636 | 4/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | BRD4 | O60885 | 1/20 | 0.46 |
| ▸ | STK17A | Q9UEE5 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1531479 | 0.81 | CDK2 (1.00) | CCNT1CDK1CCNB1CCNE1CDK2 | |
| SCHEMBL11295191 | 0.80 | CDK2 (0.74) | CCNT1CDK1CCNB1CCNE1CDK2 | |
| SCHEMBL1531503 | 0.80 | CDK2 (1.00) | CCNT1CDK1CCNB1CCNE1CDK2 | |
| SCHEMBL1531474 | 0.79 | CDK2 (1.00) | CCNT1CDK1CCNB1CCNE1CDK2 | |
| SCHEMBL1531473 | 0.79 | CDK2 (1.00) | CCNT1CDK1CCNB1CCNE1CDK2 | |
| SCHEMBL1531520 | 0.79 | CDK2 (1.00) | CCNT1CDK1CCNB1CCNE1CDK2 | |
| SCHEMBL1531622 | 0.79 | CDK2 (1.00) | CCNT1CDK1CCNB1CCNE1CDK2 | |
| SCHEMBL1531510 | 0.79 | CDK2 (1.00) | CCNT1CDK1CCNB1CCNE1CDK2 | |
| SCHEMBL1531440 | 0.77 | CDK2 (1.00) | CCNT1CDK1CCNB1CCNE1CDK2 | |
| SCHEMBL2430242 | 0.76 | CCNT1 (0.72) | CCNT1CDK1CCNB1CCNE1CDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110195968-A1 | THIAZOLES AS FUNGICIDES | BAYER CROPSCIENCE AG (DE) | 2011-08-11 | — | — | US | disclosed |
| US-20090030024-A1 | THIAZOLES AS FUNGICIDES | BAYER CROPSCIENCE AG (DE) | 2009-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090030024-A1 | THIAZOLES AS FUNGICIDES | CYP4X1, CYP4Z1, RDX | CCNT1 513/4885CDK1 793/4885CCNB1 766/4885 |
| US-20110195968-A1 | THIAZOLES AS FUNGICIDES | CYP4X1, CYP4Z1, CYP3A4 | CCNT1 528/4885CDK1 857/4885CCNB1 772/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.